Atrium Innovations announces multi-year research commitment

Atrium Innovations announces multi-year research commitment

Atrium Innovations Inc. announced a multi-year commitment to nutrition research and to a comprehensive program focusing on metabolic syndrome. Atrium’s research involves gaining a better understanding of metabolic syndrome and investigating the impact of nutrition on the prevention and treatment of silent inflammation associated with this condition.

Atrium Innovations, Inc. (TSX: ATB), a recognized leading developer, manufacturer and marketer of professionally endorsed, science-based dietary supplements for the health and nutrition industry, announced a multi-year commitment to nutrition research and to a comprehensive program focusing on metabolic syndrome. This global effort will be conducted in collaboration with a strategic partner, the Institute of Nutraceuticals and Functional Foods (INAF). The total current funding for related projects planned and in progress is over $5 million, and includes partial support from governmental agencies.

“We have always believed in the importance of research. This investment provides further indication of the depth of our commitment,” said Pierre Fitzgibbon, President and CEO. “Applying a more sophisticated science-based approach to our whole spectrum of products, we have the ability to positively affect the quality of life of people by helping them maintain their health and prevent serious diseases.”

Atrium’s research involves gaining a better understanding of metabolic syndrome and investigating the impact of nutrition on the prevention and treatment of silent inflammation associated with this condition. More specifically, its research will emphasize the health benefits of small fruits, the anti-inflammatory mechanisms of specific fish oil fractions in the prevention of cardiovascular disease, probiotics and systemic enzyme therapy in the management of inflammation, and health promotion.

“We have a duty to ensure that health care professionals, their patients and health-conscious consumers have access to safe and effective nutritional products,” said Dr. Barry W. Ritz, Vice President, Scientific and Regulatory Affairs. “We have aligned ourselves with a strategic academic partner to conduct the most comprehensive program of cutting-edge research on the role of nutritional therapies in managing metabolic syndrome.”

Based at Université Laval, INAF is among the largest research centers in the world, dedicating all of its research efforts to advancing knowledge in the area of nutrition and health, with an expertise in studying functional food ingredients and dietary supplements. It is widely recognized in Canada and abroad for its innovative and targeted approach, as well as for the quality of its research and the expertise of its members.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish